Terumo Corp. (OTCMKTS:TRUMY) Short Interest Up 80.3% in July

Terumo Corp. (OTCMKTS:TRUMY) was the recipient of a large growth in short interest in July. As of July 15th, there was short interest totaling 85,412 shares, a growth of 80.3% from the June 30th total of 47,370 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average trading volume of 287,234 shares, the short-interest ratio is currently 0.3 days.

Analyst Ratings Changes

Separately, Zacks Research upgraded Terumo to a “hold” rating in a research report on Thursday, April 9th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Terumo has a consensus rating of “Hold”.

Terumo Stock Up 5.8%

Terumo stock opened at $14.85 on Thursday. The stock has a market cap of $21.90 billion, a price-to-earnings ratio of 24.34 and a beta of 0.68. The company has a current ratio of 1.59, a quick ratio of 0.97 and a debt-to-equity ratio of 0.06. The company’s 50-day moving average price is $14.01 and its two-hundred day moving average price is $13.53. Terumo has a 52 week low of $12.08 and a 52 week high of $19.60.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings results on Friday, May 15th. The company reported $0.11 EPS for the quarter, hitting analysts’ consensus estimates of $0.11. The company had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.84 billion. Terumo had a net margin of 12.09% and a return on equity of 9.17%. On average, analysts expect that Terumo will post 0.7 EPS for the current fiscal year.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.